CELLADON CORP's ticker is CLDN and the CUSIP is 15117E107. A total of 69 filers reported holding CELLADON CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $27,370,000 | -0.2% | 1,445,100 | +2.9% | 1.35% | -15.9% |
| Q4 2014 | $27,416,000 | +79.9% | 1,403,800 | -3.7% | 1.61% | +41.3% |
| Q3 2014 | $15,242,000 | -35.2% | 1,457,200 | -0.8% | 1.14% | -35.0% |
| Q2 2014 | $23,522,000 | -33.8% | 1,468,300 | -50.8% | 1.75% | +19.2% |
| Q1 2014 | $35,558,000 | – | 2,983,000 | – | 1.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,066,774 | $17,090,000 | 5.75% |
| Palo Alto Investors LP | 1,468,300 | $23,522,000 | 1.75% |
| Tekla Capital Management LLC | 970,495 | $13,215,000 | 1.21% |
| SHAKER INVESTMENTS LLC/OH | 71,000 | $1,137,000 | 0.74% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,000 | $2,403,000 | 0.59% |
| HighTower Advisors, LLC | 1,950,184 | $31,242,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 46,000 | $737,000 | 0.22% |
| PFM Health Sciences, LP | 397,516 | $6,368,000 | 0.13% |
| Baldwin Investment Management, LLC | 14,593 | $234,000 | 0.10% |
| Visium Asset Management, LP | 331,680 | $5,314,000 | 0.08% |